Quarterly Result9 Mar 2026, 06:11 pm
Vivimed Labs Ltd Schedules Board Meeting to Approve Q3 and Nine Months Financial Results for 2025
AI Summary
Vivimed Labs Ltd, a company with CIN: LO2411KA1988PLCO09445, has announced that its Board of Directors will meet on 13th March 2026 to consider and approve the un-audited Financial Results (Standalone & Consolidated) for the quarter and nine months ending 31st December 2025. The meeting will take place at the company's registered office in Hyderabad, India.
Key Highlights
- Vivimed Labs Ltd to hold a Board Meeting on 13th March 2026
- The meeting will consider and approve un-audited Financial Results for the quarter and nine months ending 31st December 2025
- The meeting will take place at the company's registered office in Hyderabad, India
Price Impact
More from VIVIMEDLAB